City and State NY - August 1, 2021
Philip Ozuah, M.D., Ph.D., and Gordon Tomaselli, M.D., jointly ranked #13 in this list of leaders cultivating New York City's fast-growing biotech and life sciences hub. Dr. Ozuah is president and CEO of Montefiore Medicine and Dr. Tomaselli is the Marilyn and Stanley M. Katz Dean at Einstein and executive vice president and chief academic officer at Montefiore Medicine.
Dr. Ozuah's Profile
New York Post - July 20, 2021
Nir Barzilai, M.D., talks about his plans for a clinical trial to study metformin, a diabetes drug, to target age-related diseases. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Medscape - July 19, 2021
Matthew Akiyama, M.D., describes his National Institutes of Health award to use new sequencing technology to understand HIV and hepatitis C transmission, which may lead to new prevention and treatment strategies for the diseases. Dr. Akiyama is associate professor of medicine at Einstein and an internist at Montefiore.
Dr. Akiyama's ProfileMore coverage on Dr. Akiyama
Science News - July 14, 2021
Suzette Olu Bousola Oyeku, M.D., M.P.H., comments on the significant increase in the number of children worldwide who have missed vaccinations for preventable diseases like measles, diphtheria, tetanus, and pertussis, and warns that clusters of outbreaks could occur as a result. Dr. Oyeku is professor of pediatrics at Einstein and chief of the division of academic general pediatrics at the Children’s Hospital at Montefiore (CHAM).
Dr. Oyeku's Profile
Medscape - July 9, 2021
Priya Nori, M.D., discusses the disagreement between Pfizer and the Centers for Disease Control about COVID-19 booster shots, and says a more important issue is vaccine equity and the need to provide initial shots for healthcare workers in low- and middle-income countries. Dr. Nori is associate professor of medicine and of orthopaedic surgery at Einstein and Montefiore.
Dr. Nori's ProfileMore coverage on Dr. Nori
National Institute on Aging - July 8, 2021
Carol Derby, Ph.D., led research in the National Institutes of Health-supported Study of Women's Health Across the Nation (SWAN) that found heart disease risk factors, such as high blood pressure, diabetes, and belly fat, were associated with declines in cognitive processing speed during midlife. Dr. Derby is research professor in the Saul R. Korey Department of Neurology and in the department of epidemiology & population health and is the Louis and Gertrude Feil Faculty Scholar in Neurology at Einstein. She is principal investigator of the Einstein site of the SWAN study underway at seven clinical centers across the United States.
Dr. Derby's Profile
The Scientist - July 1, 2021
Libusha Kelly, Ph.D., describes SARS-CoV-2 sequencing efforts at Einstein and Montefiore and calls for a robust national genomic sequencing program to help scientists detect, understand, and stay ahead of new and developing viral variants. Dr. Kelly is associate professor of systems & computational biology and of microbiology & immunology.
Dr. Kelly's ProfileMore coverage on Dr. Kelly
The Washington Post - June 17, 2021
Richard Lipton, M.D., says he supports the FDA's approval of a controversial new drug to treat Alzheimer's, and notes that he would have given the drug to his late mother, who suffered from the disease. Dr.Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein and Montefiore.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
Daily Mail - June 10, 2021
Balazs Halmos, M.D., and Amit Verma, M.B.B.S., comment on their study that finds patients with cancer developed antibodies to COVID-19 after vaccination. Dr. Halmos is director of the Multidisciplinary Thoracic Oncology Program at Montefiore and professor of medicine at Einstein; Dr. Verma is associate director of translational science at the Albert Einstein Cancer Center and director of the division of hemato-oncology at Montefiore.
Dr. Halmos' Profile
The New York Times - June 4, 2021
An Einstein alumna and current Montefiore resident shares her experiences graduating during the height of the pandemic in spring 2020 and starting her career caring for critically ill patients with COVID-19.
The Boston Globe - June 4, 2021
Tia Powell, M.D., explains that a diagnosis of Alzheimer's disease is often accompanied by shame and fear, which can increase the burden on caretakers. Dr. Powell is the Dr. Shoshana Trachtenberg Frackman Faculty Scholar in Biomedical Ethics and director of the Montefiore Einstein Center for Bioethics.
Dr. Powell's ProfileMore coverage on Dr. Powell
Fast Company - June 4, 2021
Maureen Brogan, M.D., discusses rhabdomyolysis, a painful and dangerous syndrome involving muscle overexertion that often results from starting or restarting a rigorous exercise regime. Dr. Brogan is associate professor of medicine at Einstein and a nephrologist at Montefiore.
Dr. Brogan's Profile
Allure - June 1, 2021
Dawn Buse, Ph.D., says people with migraine can still experience fatigue and difficulty concentrating in the postdrome phase of migraine, when most of the other severe headache symptoms have resolved. Dr. Buse is clinical professor in the Saul R. Korey Department of Neurology.
Dr. Buse's ProfileMore coverage on Dr. Buse
American Heart Association News - May 21, 2021
Jonathan Oxman, M.D., a 2021 graduate of Einstein, describes the research he conducted at the College of Medicine that found a link between perceived discrimination by Hispanic adults and changes in their cardiac structure and function that could lead to cardiovascular disease.
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski